GennadyBratslavskyMD

Professor and Chair of Urology Division Chief of Upstate Urology at 550 Harrison Division Chief of Urologic Male Health Director of Prostate Cancer Program Department Chief of Adult Urology Clinic Department Chief of Urologic Oncology SUNY Upstate Medica

Join to view full profile

Dr. Bratslavsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bratslavsky's full profile

Already have an account?

Office
750 E Adams St
Syracuse, NY 13210
Phone+1 315-464-6106

Fax+1 315-464-6117

Education & Training

Albany Medical CenterResidency, Urology, 2000 - 2005
Albany Medical CollegeClass of 2000

Certifications & Licensure

NY State Medical License 2011 - 2026
PA State Medical License 2013 - 2018
VA State Medical License 2005 - 2012
American Board of Urology Urology

Clinical Trials

Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer Start of enrollment: 2011 Dec 01
Completed
Early Phase 1

Publications & Presentations

PubMed

Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database.
Maroun Bou Zerdan, Stephanie Niforatos, Swathi Arunachalam, Tamara Jamaspishvili, Roger Wong
Clinical Genitourinary Cancer. 2024-12-01
COVID-19 testing and financial toxicity in cancer survivors.
John M Panzone, Gavrielle J Rood, Maximillian S Wu, Fumiko Chino, Alicia Morgans
Supportive Care in Cancer. 2024-11-23
Metastasis development in non-muscle-invasive bladder cancer.
Michael Leyderman, Thenappan Chandrasekar, Petros Grivas, Roger Li, Seetharam Bhat
Nature Reviews. Urology. 2024-11-20

Lectures

Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Malignant pheochromocytoma (MP): A comprehensive genomic profiling (CGP) study.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
PBRM1Â mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Current Concepts in Mens Health 2012
Albany Medical College, Bolton Landing, New York - 8/17/2012
Join now to see all

Press Mentions

Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in the Lancet OncologyNovember 30th, 2020
Upstate Professors to Present at International Cancer Conference in SpainSeptember 27th, 2019
Cytoreductive Nephrectomy May Benefit RCC Patients with Brain MetsDecember 12th, 2018
Join now to see all